Schreiner MediPharm, a Germany-based global provider of functional labels for the healthcare industry, has developed an NFC-Label for Ypsomed’s UnoPen, helping patients in combination with the SmartPilot add-on to properly utilize the device and adhere to therapy plans. Diabetes patients depending on lifelong insulin treatment must administer the vital medication to themselves using insulin pumps, syringes or pens. Ypsomed offers UnoPen, a disposable pen with variable dose setting, for this and other multidose therapies. Schreiner MediPharm’s NFC-Label serves as a communication interface between the injector and an electronic pen add-on called SmartPilot. Combined, the NFC-Label and SmartPilot comprise a smart device that interactively supports patients in using the pen, and helps them adhere to therapy regimens.